GGrantIndex
Sort

50,496 grants matching lung cancer

Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis

$687,328
Magdalena Karbowniczek · Texas Tech University Health Scis Center · R01 · FY2025 · HL

Molecular Phenotypes for Lung Diseases

$687,318
David Brian Corry · Baylor College Of Medicine · R01 · FY2011 · HL

Probabilistic Multiscale Modeling of the Tumor Microenvironment

$687,286
Wesley Tansey · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA

A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer

$687,076
Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA

Project 4: The role of codon bias in RAS tumorigenesis

$687,054
Christopher M Counter · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA

Biomolecular Recognition and Binding Mechanisms

$687,053
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Assessing the integration of tobacco cessation treatment into lung cancer screening

$686,996
Elyse R Park · Massachusetts General Hospital · R01 · FY2019 · CA

A novel preclinical model of spontaneous metastasis

$686,928
Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Role of Novel Cytokine Secretoglobin (SCGB) 3A2 in Lung

$686,816
Shioko Kimura · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

MINIMALLY INVASIVE SURGERY IN THORACIC MALIGNANCIES

$686,748
Dana-Farber Cancer Institute · U01 · FY2001 · CA

Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA

$686,710
Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers

$686,621
Scarlett L Gomez · University Of California, San Francisco · R01 · FY2021 · MD

Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation

$686,465
Saro Armenian · Beckman Research Institute/City Of Hope · R01 · FY2024 · HL

Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells

$686,463
David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Leadership, Planning, and Evaluation

$686,254
Stanton L Gerson · Case Western Reserve University · P30 · FY2022 · CA

1/1 Urinary Stone Disease Washington University Research Network

$686,250
Hing Hung Henry Lai · Washington University · U01 · FY2016 · DK

Optimizing Lung Cancer Screening Nodule Evaluation

$686,206
Chung Yin Kong · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Optimizing Lung Cancer Screening Nodule Evaluation

$686,206
Chung Yin Kong · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA

Fox COBRE Phase II Admin Core

$686,141
Joseph M Fox · University Of Delaware · P20 · FY2020 · GM

Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking

$686,074
Jonathan B Bricker · Fred Hutchinson Cancer Center · R01 · FY2022 · CA

Development and Translation of Advanced Motion Correction Technologies for Cardiac PET/CT

$686,047
Chi Liu · Yale University · R01 · FY2025 · HL

NOX family NADPH oxidases: roles in innate immunity and inflammatory disease

$686,028
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Impact of Cryptococcus titan cells on pathogenesis

$685,902
Kirsten Nielsen · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · AI

New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells

$685,832
Sandra Aung · Ubivac, Llc · R44 · FY2010 · CA

ENDOPLASMIC RETICULUM-TARGETED RADIODYNAMIC THERAPY FOR THE TREATMENT OF LUNG CANCER

$685,778
University Of Georgia Research Foundation, Inc. · · FY2024 · Defense Health Agency